GB2316681B - Antigenically active proteins/polypeptides and coronavirus vaccines containing the same - Google Patents

Antigenically active proteins/polypeptides and coronavirus vaccines containing the same

Info

Publication number
GB2316681B
GB2316681B GB9722558A GB9722558A GB2316681B GB 2316681 B GB2316681 B GB 2316681B GB 9722558 A GB9722558 A GB 9722558A GB 9722558 A GB9722558 A GB 9722558A GB 2316681 B GB2316681 B GB 2316681B
Authority
GB
United Kingdom
Prior art keywords
polypeptides
same
active proteins
vaccines containing
antigenically active
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
GB9722558A
Other versions
GB9722558D0 (en
GB2316681A (en
Inventor
Michel Bublot
Wannemaeker Catherine De
Didier Colau
Philippe Roux-Salembien
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dimminaco AG
Original Assignee
Dimminaco AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dimminaco AG filed Critical Dimminaco AG
Priority to GB9722558A priority Critical patent/GB2316681B/en
Publication of GB9722558D0 publication Critical patent/GB9722558D0/en
Publication of GB2316681A publication Critical patent/GB2316681A/en
Application granted granted Critical
Publication of GB2316681B publication Critical patent/GB2316681B/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/215—Coronaviridae, e.g. avian infectious bronchitis virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C07K14/08—RNA viruses
    • C07K14/165—Coronaviridae, e.g. avian infectious bronchitis virus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
    • C12N2710/16741—Use of virus, viral particle or viral elements as a vector
    • C12N2710/16743—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/20011—Coronaviridae
    • C12N2770/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/20011—Coronaviridae
    • C12N2770/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
GB9722558A 1993-09-16 1993-09-16 Antigenically active proteins/polypeptides and coronavirus vaccines containing the same Expired - Fee Related GB2316681B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB9722558A GB2316681B (en) 1993-09-16 1993-09-16 Antigenically active proteins/polypeptides and coronavirus vaccines containing the same

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9722558A GB2316681B (en) 1993-09-16 1993-09-16 Antigenically active proteins/polypeptides and coronavirus vaccines containing the same
GB9319212A GB2282601B (en) 1993-09-16 1993-09-16 Antigenically-active proteins/polypeptides and coronavirus vaccines containing the same

Publications (3)

Publication Number Publication Date
GB9722558D0 GB9722558D0 (en) 1997-12-24
GB2316681A GB2316681A (en) 1998-03-04
GB2316681B true GB2316681B (en) 1998-04-15

Family

ID=10742112

Family Applications (2)

Application Number Title Priority Date Filing Date
GB9319212A Expired - Fee Related GB2282601B (en) 1993-09-16 1993-09-16 Antigenically-active proteins/polypeptides and coronavirus vaccines containing the same
GB9722558A Expired - Fee Related GB2316681B (en) 1993-09-16 1993-09-16 Antigenically active proteins/polypeptides and coronavirus vaccines containing the same

Family Applications Before (1)

Application Number Title Priority Date Filing Date
GB9319212A Expired - Fee Related GB2282601B (en) 1993-09-16 1993-09-16 Antigenically-active proteins/polypeptides and coronavirus vaccines containing the same

Country Status (10)

Country Link
EP (1) EP0720654A1 (en)
JP (1) JPH09509562A (en)
KR (1) KR960705047A (en)
AU (1) AU7615894A (en)
BR (1) BR9407507A (en)
CA (1) CA2171869A1 (en)
GB (2) GB2282601B (en)
NO (1) NO961086L (en)
WO (1) WO1995007987A2 (en)
ZA (1) ZA946887B (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2724385B1 (en) * 1994-08-29 1996-12-13 Rhone Merieux FELINE INFECTIOUS PERITONITIS VACCINE.
FR2741806B1 (en) * 1995-11-30 1998-02-20 Rhone Merieux RECOMBINANT LIVING VACCINE BASED ON TYPE 1 FELINE HERPESVIRUS, PARTICULARLY AGAINST FELIN INFECTIOUS PERITONITIS
WO1998001570A2 (en) * 1996-07-05 1998-01-15 Vanderbilt University Mutated antibody-dependent infection enhancing domains of hiv
FR2751223B1 (en) * 1996-07-19 1998-12-04 Rhone Merieux FELIN POLYNUCLEOTIDE VACCINE FORMULA
CN1223605C (en) * 2003-05-16 2005-10-19 中国科学院微生物研究所 Polypeptide medicine for inhibiting SARS coronavirus, and derivatives and use thereof
CN113321714B (en) * 2020-02-28 2022-12-09 深圳市亚辉龙生物科技股份有限公司 Recombinant N protein of SARS-CoV-2 and its preparation and purification method
US20230331782A1 (en) * 2020-09-08 2023-10-19 The Trustees Of The University Of Pennsylvania Compositions and Methods for Reducing Risk of Vaccine-Enhanced Disease

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0376744A1 (en) * 1988-12-30 1990-07-04 Scios Nova Inc. Feline infectious peritonitis virus diagnostic tools

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL76751A (en) * 1984-11-01 1991-04-15 American Home Prod Method and oral vaccines against infectious organisms using live,recombinant adenovirus for the production of antibodies
EP0264979A1 (en) * 1986-09-05 1988-04-27 Duphar International Research B.V New antigenically active proteins and peptides, and feline infectious peritonitis virus (FIPV) vaccines
CA2020740A1 (en) * 1989-07-12 1991-01-13 Harry Vennema Antigenically active proteins/peptides, and feline infectious peritonitis virus (fipv)-vaccines
NZ240558A (en) * 1990-11-14 1994-11-25 Smithkline Beecham Corp Recombinant feline coronavirus s proteins useful in diagnosis and vaccination against feline peritonitis virus disease
JPH07504897A (en) * 1992-02-18 1995-06-01 パーヘリオン　コーポレーション Feline infectious peritonitis vaccine and preparation method
EP0640097A4 (en) * 1992-05-08 1997-01-15 Smithkline Beecham Corp Compositions and methods for vaccination against coronaviruses.
AU670092B2 (en) * 1992-05-08 1996-07-04 Pfizer Inc. Canine coronavirus S gene and uses therefor

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0376744A1 (en) * 1988-12-30 1990-07-04 Scios Nova Inc. Feline infectious peritonitis virus diagnostic tools

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Journal of General Virology, Vol. 73, 1992, pages 2849 to 2862 *

Also Published As

Publication number Publication date
AU7615894A (en) 1995-04-03
ZA946887B (en) 1995-06-27
GB2282601A (en) 1995-04-12
CA2171869A1 (en) 1995-03-23
NO961086D0 (en) 1996-03-15
GB2282601B (en) 1998-04-15
GB9722558D0 (en) 1997-12-24
JPH09509562A (en) 1997-09-30
WO1995007987A2 (en) 1995-03-23
EP0720654A1 (en) 1996-07-10
GB9319212D0 (en) 1993-11-03
KR960705047A (en) 1996-10-09
BR9407507A (en) 1997-01-07
GB2316681A (en) 1998-03-04
WO1995007987A3 (en) 1995-06-22
NO961086L (en) 1996-05-09

Similar Documents

Publication Publication Date Title
EP0950665A4 (en) Modified physiologically active proteins and medicinal compositions containing the same
DE69526801T2 (en) AEROSOL FORMULATIONS WITH PEPTIDES AND PROTEINS
HUP0103793A3 (en) N-(2-aryl-propionyl)-sulfonamids, their use and pharmaceutical preparations containing them
HUP9904031A3 (en) Insulin preparations containing nacl
EP0960885A4 (en) Depsipeptides and drugs containing the same as the active ingredient
GR3031296T3 (en) Cyclic peptides and use thereof
AU633294B2 (en) Motilin-like polypeptide and use thereof
GB9504040D0 (en) Arylsulfonamide derivative and pharmaceutical composition containing the same
GB9325496D0 (en) Vaccines
ZA9410318B (en) Phenylmethyl hexanamides and the use thereof
ZA9410217B (en) Recombinant human thymopoietin proteins and uses therefor.
GB2316681B (en) Antigenically active proteins/polypeptides and coronavirus vaccines containing the same
IL130348A0 (en) Imidazopyridazines and medicaments containing the same
EP0970965A4 (en) Cyclic peptides and medicinal use thereof
IL110954A0 (en) Pharmaceutical compositions comprising a retinoblastoma polypeptide or protein, and methods for the preparation and use thereof
GB9317752D0 (en) New pharmaceutical use
IL125535A0 (en) An aqueous formulation comprising bambuterol and the use thereof
GB9302553D0 (en) Pharmaceutical preparations and their manufacture and use
GB9322702D0 (en) Vaccines
GB9322808D0 (en) Vaccines
ZA902869B (en) Novel peptides,and antidementia agents containing the same
HRP950267A2 (en) Heterocyclic compounds, pharmaceutical preparations containing them and the preparation thereof
ZA944483B (en) Peptides for use in medicine
IE891651L (en) Amphiphilic peptides and use thereof
CA73238S (en) Combined inhaler and cap

Legal Events

Date Code Title Description
PCNP Patent ceased through non-payment of renewal fee

Effective date: 19980916